Neuroleptic malignant syndrome

被引:160
作者
Adnet, P [1 ]
Lestavel, P [1 ]
Krivosic-Horber, R [1 ]
机构
[1] Univ Hosp, Dept Anesthesiol & Emergency Med, Lille, France
关键词
anaesthetics i.v; neuroleptics; hyperthermia; malignant; pharmacology;
D O I
10.1093/bja/85.1.129
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[No abstract available]
引用
收藏
页码:129 / 135
页数:7
相关论文
共 50 条
[1]  
ADITYANJEE SS, 1988, BRIT J PSYCHIAT, V153, P107
[2]   THE ASSOCIATION BETWEEN THE NEUROLEPTIC MALIGNANT SYNDROME AND MALIGNANT HYPERTHERMIA [J].
ADNET, PJ ;
KRIVOSICHORBER, RM ;
ADAMANTIDIS, MM ;
HAUDECOEUR, G ;
ADNETBONTE, CA ;
SAULNIER, F ;
DUPUIS, BA .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1989, 33 (08) :676-680
[3]   EFFECTS OF CALCIUM-FREE SOLUTION, CALCIUM-ANTAGONISTS, AND THE CALCIUM AGONIST BAY K-8644 ON MECHANICAL RESPONSES OF SKELETAL-MUSCLE FROM PATIENTS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA [J].
ADNET, PJ ;
KRIVOSICHORBER, RM ;
ADAMANTIDIS, MM ;
REYFORD, H ;
CORDONNIER, C ;
HAUDECOEUR, G .
ANESTHESIOLOGY, 1991, 75 (03) :413-419
[4]  
ADNET PJ, 1991, ANESTH ANALG, V74, P105
[5]   NEUROLEPTIC MALIGNANT SYNDROME - CAFFEINE CONTRACTURE OF SINGLE MUSCLE-FIBERS AND MUSCLE PATHOLOGY [J].
ARAKI, M ;
TAKAGI, A ;
HIGUCHI, I ;
SUGITA, H .
NEUROLOGY, 1988, 38 (02) :297-301
[6]   Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: A case-control study [J].
Berardi, D ;
Amore, M ;
Keck, PE ;
Troia, M ;
Dell'Atti, M .
BIOLOGICAL PSYCHIATRY, 1998, 44 (08) :748-754
[7]  
BLINGH J, 1971, J PHYSL, V212, P377
[8]   PHOSPHORUS NUCLEAR MAGNETIC-RESONANCE EVIDENCE OF ABNORMAL SKELETAL-MUSCLE METABOLISM IN CHRONIC-ALCOHOLICS [J].
BOLLAERT, PE ;
ROBINLHERBIER, B ;
ESCANYE, JM ;
BAUER, P ;
LAMBERT, H ;
ROBERT, J ;
LARCAN, A .
NEUROLOGY, 1989, 39 (06) :821-824
[9]  
BOND WS, 1984, CLIN PHARMACY, V3, P302
[10]   NEUROLEPTIC MALIGNANT SYNDROME CAUSED BY DOPAMINE-DEPLETING DRUGS IN A PATIENT WITH HUNTINGTON DISEASE [J].
BURKE, RE ;
FAHN, S ;
MAYEUX, R ;
WEINBERG, H ;
LOUIS, K ;
WILLNER, JH .
NEUROLOGY, 1981, 31 (08) :1022-1026